Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Neuropharmacology. 2012 Sep 13;65:90–100. doi: 10.1016/j.neuropharm.2012.09.005

Table 3.

Leptin peptide content in ARC and VTA punches with short-term leptin overexpression.

rAAV-Control (ng/punch) rAAV-Leptin into VTA (ng/punch) rAAV-Leptin into MBH (ng/punch)
ARC 0.26 ± 0.04 0.25 ± 0.04 6.78 ± 3.32a
VTA 0.29 ± 0.03 10.58 ± 1.75b 0.31± 0.06

ARC and VTA punch represents a cylinder of 2mm in length and 1mm in diameter.

Values represent the mean ± SE of 6-8 rats per group.

a

P<0.01 for difference with leptin injection by one-way ANOVA. P<0.05 for difference between rAAV-Leptin treated and rAAV-Control by Bonferroni post-hoc analysis.

b

P<0.001 for difference with leptin injection by one-way ANOVA. P<0.05 for difference between rAAV-Leptin treated and rAAV-Control by Bonferroni post-hoc analysis.